# Direct Diagnosis of Disseminated Lyme Borreliosis.

> **NCT04719962** · NA · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 10 (estimated)

## Conditions studied

- Lyme Disease

## Interventions

- **PROCEDURE:** Targeted proteomics in skin +/- cerebrospinal or synovial fluid to diagnose disseminated Lyme disease

## Key facts

- **NCT ID:** NCT04719962
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-07
- **Primary completion:** 2021-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04719962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04719962, "Direct Diagnosis of Disseminated Lyme Borreliosis.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04719962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*